Semax

ACTH-fragment analog

For laboratory research use only

Overview

Semax is a synthetic seven-amino-acid analogue based on a fragment of the naturally occurring hormone ACTH. Preclinical research examines cortical gene expression after experimental brain ischemia. [1]

Identity

Compound classSynthetic ACTH-fragment analog
Length7 amino-acid residues
Reference compoundSemax
CAS number80714-61-0
Molecular formulaC37H51N9O10S
Molecular weight813.9 g/mol
SourcePubChem CID 9811102

Published research

Animal study · Protein abundance

Dolotov and colleagues studied Semax binding and measured BDNF protein in rat basal forebrain. A regional tissue measurement captures the combined signal of the cells in that sample. Dolotov and colleagues found specific Semax binding and increased BDNF protein in rat basal forebrain. [1]

Animal study · Gene expression after ischemia

In a rat focal-ischemia model, investigators compared cortical gene expression with that of ischemia controls. Differences involved groups of genes linked to immune responses and vascular processes. Compared with ischemic controls, Semax-exposed rats showed changes in immune- and vascular-related gene expression, with prominent increases in immunoglobulin and cytokine transcripts at 24 hours. [2]

Where the evidence stands

One rat study found a regional increase in BDNF protein. Another found a time-dependent cortical transcriptional response after focal ischemia. Together they support measurable molecular responses in rat brain tissue. Neither outcome on its own demonstrates functional recovery. [1] [2]

Frequently asked questions

What does BDNF stand for?

Brain-derived neurotrophic factor.

What material was discussed in the cited paper?

The authors described Semax, a synthetic ACTH-fragment analog.

References

  1. Dolotov et al. (2006), Semax in rat basal forebrain
  2. Semax and cortical gene expression in rats | BMC Genomics, 2014

Interested in Researching Semax?
View Semax in PURUS Research Catalog.

Related pages